Idenix Pharmaceuticals (IDIX) Reports In-Line Q4 Loss of 17c/Share

February 25, 2013 4:09 PM EST Send to a Friend
Get Alerts IDIX Hot Sheet
Price: $24.50 --0%

Financial Fact:
Loss from operations: -64.75M

Today's EPS Names:
CCL, PAYX, BBRY, More
Trade IDIX Now!
Join SI Premium – FREE
Idenix Pharmaceuticals (NASDAQ: IDIX) reported Q4 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $327 thousand versus the consensus estimate of $740 thousand.

For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment